Athira Pharma

Athira Pharma is a late clinical-stage biopharmaceutical company dedicated to developing small molecules that restore neuronal health and slow neurodegeneration. Their scientific philosophy is rooted in supporting a healthy neuronal network, with a focus on improving the lives of patients and caregivers by maintaining their personal connections. Athira's novel approach involves designing small molecules to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system, which is critical for normal brain function.

Athira is currently conducting clinical trials evaluating the safety and efficacy of its investigational therapies in various neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease Dementia, Dementia with Lewy Bodies, and Amyotrophic Lateral Sclerosis (ALS). The company's lead program, fosgonimeton (ATH-1017), is designed to promote brain health and function by enhancing the HGF system. Athira is committed to building, restoring, and maintaining connections, both at the cellular level and in the lives of patients and their families.

Athira Pharma offers a flexible work environment, allowing employees to find balance and thrive both at work and in life. This includes flexible work arrangements and opportunities for professional development.

Athira Pharma offers a competitive benefits package designed to support employee well-being and growth. This includes comprehensive health coverage, a 401(k) plan with a company match, a flexible spending account, an employee stock purchase plan, paid time off, paid holidays, a year-end holiday closure, professional development opportunities, and a flexible work environment. These benefits aim to provide employees with financial security, personal and professional development opportunities, and a work-life balance.

Athira Pharma is a late clinical-stage biopharmaceutical company dedicated to restoring neuronal health and slowing neurodegeneration. They are focused on developing small molecules that enhance the naturally occurring neurotrophic hepatocyte growth factor (HGF) system, which is crucial for brain function. By promoting regeneration, providing neuroprotection, and potentially modifying the course of neurodegenerative diseases, Athira aims to restore and maintain both neuronal and personal connections, improving the lives of patients and caregivers.

Athira Pharma promotes a culture of purpose-driven innovation and teamwork, emphasizing the importance of both neuronal and personal connections. They value collaboration, diversity, and individual contributions, fostering a sense of camaraderie and urgency to make a difference in the lives of patients suffering from neurological diseases. The company prioritizes integrity, perseverance, and transformation, encouraging employees to think outside the box, embrace change, and work together to achieve their goals.

Athira Pharma prioritizes building a diverse and inclusive workplace that values individual contributions and fosters a sense of belonging. They believe in creating a culture where everyone feels respected, supported, and empowered to reach their full potential. This commitment to diversity, equity, and inclusion is reflected in their values, which emphasize collaboration, inclusion, and the importance of every voice. They are actively working to build a company that is representative of the diverse communities they serve and are committed to providing a welcoming and inclusive environment for all employees.